ro5545965
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2012 (NCT01711801)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Phosphodiesterase 10AINHIBITOR
PDE10A inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ro5545965
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02824055 | Phase 1 | Jun 27, 2016 | Roche |
| NCT02019329 | Phase 1 | Jan 1, 2014 | Roche |
| NCT01923025 | Phase 1 | Aug 1, 2013 | Roche |
| NCT01864226 | Phase 1 | Jun 1, 2013 | Roche |
| NCT01711801 | Phase 1 | Oct 1, 2012 | Roche |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Roche | For profit | 5 | 5 | 1 | 2012 |
1 organizations
Page 1 / 1